In Vivo Zebrafish GFAP ELISA for Neurotoxicity

Information

  • Research Project
  • 7482582
  • ApplicationId
    7482582
  • Core Project Number
    R43MH086086
  • Full Project Number
    1R43MH086086-01
  • Serial Number
    86086
  • FOA Number
    PA-07-80
  • Sub Project Id
  • Project Start Date
    9/17/2008 - 16 years ago
  • Project End Date
    5/16/2010 - 14 years ago
  • Program Officer Name
    GOLANOV, EUGENE V
  • Budget Start Date
    9/17/2008 - 16 years ago
  • Budget End Date
    5/16/2010 - 14 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/16/2008 - 16 years ago

In Vivo Zebrafish GFAP ELISA for Neurotoxicity

[unreadable] DESCRIPTION (provided by applicant): Toxic damage to the nervous system results in direct damage/death of neurons and glial cells. Since drug reaction varies with type of neuron, neurotoxicity assays based on the characteristics of one type of neuron do not necessarily predict the effect of different drug classes on other types of neurons. Glial cells, on the other hand, support all neurons, and activation of astrocytes, a type of glial cells, (astrogliosis) has been linked with every form of brain injury, including: drug-induced neurotoxicity, ischemic stroke, neurodegenerative disease, and tumors. Using zebra fish, this SBIR proposes to develop a rapid in vivo assay for assessing drug induced neurotoxicity. Zebra fish is a good animal model for toxicity testing. Development of the zebra fish CNS has been extensively studied and many regulatory and morphological features are highly conserved. The zebra fish assay permits evaluation of the therapeutic potential of a compound in a complex physiological environment using throughput similar to cell-based assays. Using cell-based screens, this information is impossible to obtain. Additional advantages of the zebra fish assay include: assay time and cost, ease of embryo maintenance during drug delivery, compatibility of assay procedures with standard microplate formats, single drug dosing for each embryo, and the ability to test large numbers of embryos for statistically significant results. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF MENTAL HEALTH
  • Activity
    R43
  • Administering IC
    MH
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    203147
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    242
  • Ed Inst. Type
  • Funding ICs
    NIMH:203147\
  • Funding Mechanism
  • Study Section
    ISD
  • Study Section Name
    Instrumentation and Systems Development Study Section
  • Organization Name
    PHYLONIX PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES